New study tests best way to protect babies from RSV: vaccine during pregnancy, antibody at birth, or both?
NCT ID NCT06551506
First seen Sep 30, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This study looks at the best way to protect babies from RSV, a serious lung infection. It compares giving a vaccine to pregnant women, giving a long-acting antibody to newborns, or using both. The goal is to see how well each approach works and how safe they are during the baby's first year. About 181 mothers and their infants are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3411, United States
-
Cincinnati Children's Hospital Medical Center Vaccine Research Center
Cincinnati, Ohio, 45229-3039, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30322-1014, United States
-
New York University School of Medicine - Langone Medical Center - Vaccine Center
New York, New York, 10016-6402, United States
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Baltimore, Maryland, 21201-1509, United States
-
University of Pittsburgh - Medicine - Infectious Diseases
Pittsburgh, Pennsylvania, 15213-3108, United States
-
University of Rochester Medical Center - Vaccine Research Unit
Rochester, New York, 14611-3201, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.